The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients ...

Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

A massive Veterans Affairs study has confirmed that nicotinamide may offer real protection against skin cancer. Patients who ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...

A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for ...

Oct 8 (Reuters) - The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ (REGN.O), opens new tab immunotherapy, Libtayo, as an add-on treatment for skin cancer patients ...

Medical groups say early detection leads to better treatment outcomes. Oct.1 marks the beginning of Breast Cancer Awareness Month, and the American Cancer Society (ACS) is commemorating 40 years of ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were most notable in people with alopecia areata and Sjögren syndrome. Findings ...

Regeneron Pharmaceuticals' Libtayo won approval to treat certain patients with cutaneous squamous cell carcinoma, a type of skin cancer, from the Food and Drug Administration. The pharmaceutical ...

A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...

BREAST CANCER TREATMENT OPTIONS, AND DOCTORS SAY THEY’RE SEEING WOMEN LIVE LONGER. ONE OF THEM ARE DRUGS, WHICH ARE CALLED ANTIBODY DRUG CONJUGATES, WHICH ARE AN ANTIBODY THAT GOES AFTER A TARGET THAT ...

Every cell in the human body operates on an intricate internal schedule, governed by circadian rhythms that synchronize our biological processes with the 24-hour cycle of day and night. Coordinated by ...